XPO1 is upregulated in pancreatic, ovarian, glioma, lung, gastric, prostate, and colorectal cancers, and these conditions are also linked to a poor prognosis.17, 18, 19, 20, 21, 22, 23, 24. Here, XPO1 is linked to central nervous system cancer.